Abstract
Psoriasis is a chronic inflammatory disease. Some authors have suggested that patients with psoriasis have an increased risk of cancer. Given the inflammatory nature of psoriasis, of ultraviolet light (UV) therapies and of immunosuppressive therapies, along with the increased prevalence of risk factors for cancer in patients with psoriasis (such as smoking), the risk of malignancy in patients with psoriasis has become a particular concern. This review aims at bringing to the fore the risk of developing cancer in psoriasis patients depending on the therapies used.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have